Fulgent Genetics, Inc. (FLGT)
19.61
-0.34
(-1.70%)
USD |
NASDAQ |
Aug 28, 16:00
19.63
+0.02
(+0.10%)
After-Hours: 20:00
Fulgent Genetics Net Income (Quarterly) : -29.72M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.72M |
| March 31, 2026 | -25.27M |
| December 31, 2025 | -23.65M |
| September 30, 2025 | -6.826M |
| June 30, 2025 | -19.26M |
| March 31, 2025 | -11.90M |
| December 31, 2024 | -6.19M |
| September 30, 2024 | -14.69M |
| June 30, 2024 | -9.09M |
| March 31, 2024 | -13.85M |
| December 31, 2023 | -134.33M |
| September 30, 2023 | -13.47M |
| June 30, 2023 | -11.59M |
| March 31, 2023 | -15.85M |
| December 31, 2022 | -24.08M |
| September 30, 2022 | 1.343M |
| June 30, 2022 | 11.10M |
| March 31, 2022 | 153.56M |
| December 31, 2021 | 103.68M |
| September 30, 2021 | 122.22M |
| June 30, 2021 | 75.91M |
| March 31, 2021 | 200.69M |
| Date | Value |
|---|---|
| December 31, 2020 | 168.07M |
| September 30, 2020 | 46.64M |
| June 30, 2020 | 3.321M |
| March 31, 2020 | -1.956M |
| December 31, 2019 | -0.296M |
| September 30, 2019 | 1.462M |
| June 30, 2019 | 0.331M |
| March 31, 2019 | -1.908M |
| December 31, 2018 | -2.053M |
| September 30, 2018 | -0.595M |
| June 30, 2018 | -1.049M |
| March 31, 2018 | -1.91M |
| December 31, 2017 | -1.775M |
| September 30, 2017 | -1.093M |
| June 30, 2017 | -0.025M |
| March 31, 2017 | 0.232M |
| December 31, 2016 | 0.813M |
| September 30, 2016 | -1.107M |
| June 30, 2016 | -4.492M |
| March 31, 2016 | -0.602M |
| December 31, 2015 | -7.337M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 333.00M |
| Labcorp Holdings, Inc. | 299.10M |
| OPKO Health, Inc. | -8.416M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.238M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 85.39M |
| Total Expenses (Quarterly) | 114.92M |
| EPS Diluted (Quarterly) | -1.054 |
| Enterprise Value | 286.51M |
| Gross Profit Margin (Quarterly) | 27.02% |
| Profit Margin (Quarterly) | -34.80% |
| Earnings Yield | -14.43% |
| Normalized Earnings Yield | -13.77 |